Literature DB >> 22008955

Lamotrigine-induced vanishing bile duct syndrome in a child.

Harsh Bhayana1, Sreekanth Appasani, B R Thapa, Ashim Das, Kartar Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22008955     DOI： 10.1097/MPG.0b013e31823c2500

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  5 in total

1.  Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.

Authors:  Matthew Mason; Oyedele Adeyi; Scott Fung; Barbara-Ann Millar
Journal:  BMJ Case Rep       Date:  2014-11-28

2.  Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.

Authors:  Herbert L Bonkovsky; David E Kleiner; Jiezhun Gu; Joseph A Odin; Mark W Russo; Victor M Navarro; Robert J Fontana; Marwan S Ghabril; Huiman Barnhart; Jay H Hoofnagle
Journal:  Hepatology       Date:  2017-02-07       Impact factor: 17.425

3.  Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.

Authors:  Naga Chalasani; Herbert L Bonkovsky; Jonathan G Stine; Jiezhun Gu; Huiman Barnhart; Elin Jacobsen; Einar Björnsson; Robert J Fontana; David E Kleiner; Jay H Hoofnagle
Journal:  J Hepatol       Date:  2021-12-22       Impact factor: 25.083

4.  Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.

Authors:  Wen Xie; Qi Wang; Yuanjiao Gao; Calvin Q Pan
Journal:  BMC Gastroenterol       Date:  2018-09-29       Impact factor: 3.067

5.  Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome.

Authors:  Hyun Jeong Cho; Hye Jeong Jwa; Kyu Seon Kim; Dae Yong Gang; Jae Young Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.